Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysis of claims data showed reduced utilization and costs among patients with nonintensively treated type 2 diabetes (T2D) using self-monitoring of blood glucose compared with continuous glucose monitoring.
EQS-News: Formycon AG / Key word(s): Half Year Results/Half Year ReportFormycon reports successful first half of 2023 30.08.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Press Release // August 30, 2023Formycon reports successful first half of 2023 Development of biosimil...
(Albany, United States) As per DelveInsight’s assessment, globally, the Gastric Cancer Pipeline constitutes 230+ key companies continuously working towards developing 230+ Gastric Cancer Pipeline treatment
Thirteen years litigating the same case is a looooong time. Absurdly long. Long enough for an attorney working on the case to go from an associate learning to coax a newborn to sleep,...
Thirteen years litigating the same case is a looooong time. Absurdly long. Long enough for an attorney working on the case to go from an associate…